deliver trial: blood based biomarker analysis of patients with gastric cancer treated with nivolumab
Published 2 years ago • 128 plays • Length 7:38Download video MP4
Download video MP3
Similar videos
-
6:10
deliver: nivolumab in advanced gastric cancer
-
2:40
biomarker analysis of nivolumab in patients with advanced refractory biliary tract cancer
-
6:31
checkmate 649 biomarker analyses of nivo ipi vs chemo for patients with gc/gejc/eac
-
8:26
deliver: investigating the efficacy of nivolumab treatment in gastric cancer
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
2:36
real-world use of nivolumab in gastric cancer
-
3:05
checkmate 648: novel treatment for patients with advanced esophageal squamous cell carcinoma
-
19:44
emerging biomarkers and novel therapies for esophageal cancer
-
43:57
gastric and gej cancer clinical case discussions
-
3:21
how is gastric cancer biomarker testing conducted?
-
2:45
current and future biomarkers for gastroesophageal cancer
-
3:58
how do biomarker test results impact a gastric cancer treatment plan?
-
7:47
molecular testing to determine gastric cancer treatment
-
10:25
fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
-
58:44
from biomarker testing to treatment: precision medicine for solid tumors (genomic testing)
-
3:34
ad-cea vaccine plus avelumab vs mfolfox6-based standard care in untreated metastatic crc
-
5:37
deliver commentary - clyde yancy, md, faha
-
58:44
from biomarker testing to treatment: precision medicine for liquid tumors
-
4:14
adjuvant nivolumab in patients with resected esophageal or gej cancer (checkmate 577)